AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

BLSM vs LYEL: stock comparison and AI forecast

Blossomhill Therapeutics, Inc. (BLSM) and Lyell Immunopharma, Inc. (LYEL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

BLSM Blossomhill Therapeutics, Inc.

Market Cap
$393M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

LYEL Lyell Immunopharma, Inc.

Market Cap
$368M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

BLSM · LYEL

Key facts

  • BLSM and LYEL have similar market capitalizations ($393M and $368M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricBLSMLYEL
Market Cap$393M$368M
P/B Ratio–1.91x
EPS–$-12.32
Book Value/Share–$7.86
Revenue/Share–$0.00
FCF/Share–$-5.71

Profitability & Margins

MetricBLSMLYEL
ROE–-132.4%
ROA–-93.2%
ROIC–-117.6%
Operating Margin–-1783580.0%
Net Margin–-1701066.7%
EBT Margin–-1783580.0%

Financial Health

MetricBLSMLYEL
Current Ratio5.42x4.02x
D/E Ratio–0.42x
Financial Leverage–1.42x
Working Capital$82M$140M

Cash Flow

MetricBLSMLYEL
Operating Cash Flow–-$139M
Free Cash Flow–-$140M
Capital Spending–-$710K
FCF/Sales–-933100.0%
CapEx/Sales–4766.7%

Operational Efficiency

MetricBLSMLYEL
Asset Turnover–0.00x
Fixed Assets Turnover–0.0x

Income Statement

MetricBLSMLYEL
Total Revenue–$10K
Operating Income–-$268M
Net Income–-$255M
R&D Expense–$169M

Dividend & Shareholder Information

MetricBLSMLYEL
Shares Outstanding32M25M
FAQ

BLSM vs LYEL: stock comparison and AI forecast

Which is bigger, BLSM or LYEL?

BLSM and LYEL have similar market capitalizations ($393M and $368M).

Which one does Intratio's AI model rank higher, BLSM or LYEL?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.